News
The Neuroendocrine Tumor Research Foundation partners with Pattern.org to enable patients to directly contribute tissue samples to research projects.
The Neuroendocrine Tumor Research Foundation is excited to be working with Pattern.org to empower patients to direct their excess cancer tissue samples to research projects.
NETRF Collaborates with ERF to Fund Nuclear Medicine NET Grant
The first NETRF/ERF Nuclear Medicine Pilot Research Grant has been awarded to Thomas Hope, MD, of the University of California at San Francisco (UCSF). NETRF
Josh Mailman Joins NETRF Board of Directors
The NETRF Board of Directors is pleased to announce that Josh Mailman has joined the Board. Josh is an internationally-recognized advocate for Neuroendocrine tumor patients
Petersen Investigator Dr. Gigi Lozano: Working to unlock the mysteries of Pancreatic Neuroendocrine Tumors
Dr. Guillermina Lozano, Ph.D. of MD Anderson Cancer Center has worked tirelessly to understand how pancreatic neuroendocrine tumors develop so that we might use that
NETRF/NANETS Names First BTSI Researcher
Dr. Christopher Heaphy of Johns Hopkins University has been selected as the first Basic Translational Science Investigator, through a collaboration between NETRF and The North
Dr. Chrissie Thirlwell Joins NETRF’s Board of Scientific Advisors
The NET Research Foundation is delighted to welcome Dr. Chrissie Thirlwell, Senior Lecturer and Consultant in Medical Oncology at the Royal Free Hospital NET Unit
NET Research Foundation Receives Transformational Gift from Margie and Robert E. Petersen Foundation
Funding to find cure for rare cancer affecting over 170,000 Americans The Neuroendocrine Tumor (NET) Research Foundation today announced that it has received a major
Accelerating Research from Bench to Bedside
CAR T (Chimeric Antigen Receptor T-cell) therapy, an immunotherapy that harnesses the body’s own T cells to kill cancer cells, showed success in treating blood